Safety
Peptide safety, plainly explained.
Cautious, evidence-based explainers on the topics that determine whether a peptide can be discussed responsibly at all.
Peptide Safety
An overview of how to think about peptide safety, including risks specific to research compounds.
Read moreWhat 'Research Use Only' Really Means
The legal and practical meaning of the 'research use only' label that appears on most peptide vials.
Read morePeptide Side Effects Explained
How adverse-event profiles are reported in the peptide literature, and how to read them critically.
Read morePeptide Legality in Australia
Educational overview of how peptides are classified in Australia.
Read moreCertificates of Analysis Checklist
What a real COA should contain — and how to spot a sloppy one.
Read moreSupplier Red Flags
Signals that a peptide supplier is operating outside the boundaries of legitimate research-use supply.
Read moreEvaluating Peptide Side Effects
How to interpret side-effect reports in peptide research and understand risk profiles.
Read morePeptide Allergies and Reactions
Understanding immune reactions, allergic responses, and hypersensitivity to peptides.
Read morePeptide Storage and Safety
Safe storage practices to prevent peptide degradation and contamination.
Read moreReconstitution and Handling Safety in Research Contexts
Safe practices for preparing and handling reconstituted peptide solutions.
Read morePeptide Quality and Contamination Risks
Understanding quality defects and contamination hazards in peptide sourcing.
Read morePeptide Bias and Marketing Claims
Recognising how marketing bias can distort peptide claims and how to find credible information.
Read moreResearch Trial Design and Safety Reporting
How to evaluate the quality of human trials and safety reporting in peptide research.
Read moreThe TGA Special Access Scheme
How the TGA Special Access Scheme allows access to unapproved peptides in defined circumstances.
Read morePeptides in Elite Sport: WADA Status
WADA regulations on peptides and the anti-doping frameworks in elite sport.
Read moreOff-Label Use Explained
What off-label use means and the legal and safety considerations.
Read morePeptide Prescriber Pathways in Australia
How qualified prescribers access and prescribe approved and restricted peptides in Australia.
Read morePeptide Importation in Australia
Legal and regulatory considerations for importing peptides into Australia.
Read moreCosmetic vs Therapeutic Peptide Claims
The distinction between cosmetic and therapeutic claims and how regulatory classification works.
Read moreHow to Evaluate a Peptide Clinic
Red flags and quality signals when assessing clinics offering peptide treatments.
Read morePeptide Research and Pregnancy
Research considerations for peptides and pregnancy, including evidence gaps and safety in vulnerable populations.
Read morePeptide Research in Paediatric Contexts
Safety and ethical considerations for peptides in children, where evidence is particularly limited.
Read morePeptide Allergens and Fillers
Understanding potential allergens in peptide preparations and the role of excipients and fillers.
Read moreInjection Site Reactions in Peptide Research
Understanding local reactions at injection sites and how to minimize discomfort and complications.
Read moreAnaphylaxis Risk in Peptide Research
Understanding anaphylactic reactions to peptides and how to recognize and respond to severe allergic responses.
Read moreResearch Vial Safety: Sterile Handling
Proper techniques for handling and preparing research peptide vials to maintain sterility and prevent contamination.
Read morePeptide Research and Diabetes Considerations
Interactions between research peptides and diabetes, including glucose effects and interactions with diabetes medications.
Read morePeptide Research and Thyroid Considerations
Interactions between research peptides and thyroid function, including monitoring and potential disruption.
Read morePeptide Research and Immune-Suppression Considerations
Interactions between research peptides and immune function, particularly for immunocompromised individuals.
Read morePeptide Research in Aged Populations
Safety and pharmacokinetic considerations for research peptides in elderly individuals.
Read more